Results 121 to 130 of about 487,050 (179)

Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control. [PDF]

Cancer Rep (Hoboken)
Obeagu EI.
europepmc   +1 more source

Editorial: AntibodyPlus therapeutics in oncology: innovative mechanisms, therapeutic strategies, and clinical advances. [PDF]

Front Oncol
Chen Y, Ren P, Chen H, He M.
europepmc   +1 more source

[Multispecific antibodies].

Postepy higieny i medycyny doswiadczalnej, 1982
openaire   +1 more source

Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives. [PDF]

Front Immunol
Lopatnikova JA, Sennikov SV.
europepmc   +1 more source

From Unmet Medical Need to Drug Candidate: A Translational Therapeutic Development Roadmap Illustrated by Dual-Payload Antibody-Drug Conjugates. [PDF]

Biomolecules
Honda T, Zhu GD.
europepmc   +1 more source

Engineering trispecific IL-2 receptor agonistic antibodies through geometry optimization for enhanced Treg targeting. [PDF]

Nat Commun
Lykhopiy V, Pollenus E, Rangan L, Stakenborg M, Tezil T, Varheust M, Tanghe G, Lambrechts N, Malviya V, De Langhe E, Matteoli G, Blanchetot C, Van Rompaey L, Schlenner SM.   +13 more
europepmc   +1 more source

Immune cell engagers in lung cancer. [PDF]

Front Immunol
Kang J, Zhang M, He Y, Chen J, Liu X, Lv Q.   +5 more
europepmc   +1 more source

Advancing immunotherapy via multiple immune cells co-engagement. [PDF]

Front Immunol
Li H, Zhang Y, Wei Q, Sun Q, Lin F, Chen PR.   +5 more
europepmc   +1 more source

Editorial: The role of epithelial-derived cytokines in airway disease. [PDF]

Front Allergy
Ortega H, Chung KF.
europepmc   +1 more source

Targeted dual selection to optimize transposon stable pool generation of multispecifics. [PDF]

MAbs
Johnston J, Tierson S, Xu Y, Mix K, Guo YJ, Zenger S, Reczek D, Hoffmann D, Hall B, Brophy V.   +9 more
europepmc   +1 more source